Regenerative medicine is a research field that develops methods to restore damaged cell or tissue function by regeneration, repair or replacement. Stem cells are the raw material of the body that is ultimately used from the point of view of regenerative medicine, and stem cell therapy uses cells themselves or their derivatives to promote responses to diseases and dysfunctions, the ultimate goal of regenerative medicine. Stem cell-derived extracellular vesicles (EVs) are recognized as an attractive source because they can enrich exogenous microRNAs (miRNAs) by targeting pathological recipient cells for disease therapy and can overcome the obstacles faced by current cell therapy agents. However, there are some limitations that need to be addressed before using miRNA-enriched EVs derived from stem cells for multiplexed therapeutic targeting in many diseases. Here, we review various roles on miRNA-based stem cell EVs that can induce effective and stable functional improvement of stem cell-derived EVs. In addition, we introduce and review the implications of several miRNA-enriched EV therapies improved by multiplexed targeting in diseases involving the circulatory system and nervous system. This systemic review may offer potential roles for stem cell-derived therapeutics with multiplexed targeting.
展开▼
机译:再生医学是一个研究领域,开发通过再生、修复或替换来恢复受损细胞或组织功能的方法。从再生医学的角度来看,干细胞是最终使用的身体原材料,干细胞疗法使用细胞本身或其衍生物来促进对疾病和功能障碍的反应,这是再生医学的最终目标。干细胞来源的细胞外囊泡 (EV) 被认为是一种有吸引力的来源,因为它们可以通过靶向病理受体细胞进行疾病治疗来富集外源性 microRNA (miRNA),并且可以克服当前细胞治疗药物面临的障碍。然而,在许多疾病中使用源自干细胞的富含 miRNA 的 EV 进行多重治疗靶向之前,需要解决一些限制。在这里,我们回顾了基于 miRNA 的干细胞 EVs 的各种作用,这些作用可以诱导干细胞衍生的 EVs 有效和稳定的功能改善。此外,我们介绍并回顾了几种富含 miRNA 的 EV 疗法在涉及循环系统和神经系统的疾病中通过多重靶向得到改善的影响。本系统综述可能为具有多重靶向的干细胞衍生疗法提供潜在作用。
展开▼